See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Sept. 25, 2006

Migraine and Cluster Headaches Contraception Erectile Dysfunction

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Migraine and Cluster Headaches

This study will evaluate an FDA-approved medicine to prevent migraine headaches. Volunteers 18-65 may be eligible who have at least a one-year history of migraines, have migraines 10-14 days per month, and are willing to substitute current migraine medicine with the study drug.

The research site is in Cincinnati, Ohio.

More information

Please see http://www.centerwatch.com/patient/studies/cat100.html.

-----

Contraception

Women are needed for this clinical research study of an investigational oral birth control medication. Women 18-45 who are sexually active and have regular menstrual cycles may be eligible. Compensation up to $150 is available for time and travel.

The research site is in Moorestown, NJ.

More information

Please see http://www.centerwatch.com/patient/studies/cat374.html.

-----

Erectile Dysfunction

This study will evaluate an investigational medication to treat abnormal cholesterol and erectile dysfunction. Men 18-64 in a stable heterosexual relationship who have had ED for at least six months and who are on a stable dose of a cholesterol-lowering drug may qualify.

The research site is in Lawrenceville, NJ.

More information

Please see http://www.centerwatch.com/patient/studies/cat371.html.

-----

Copyright 2006 Thomson CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.